Jinling Pharmaceutical Company Limited

SZSE:000919.SZ

7.85 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 2,785.7382,670.9682,808.7552,503.7322,534.9212,899.0793,191.8123,578.6533,221.3752,771.9422,605.7142,304.9342,257.0232,161.1391,966.7061,788.8821,548.9691,375.7341,235.81,001.753849.717629.56499.417364.95354.136339.045301.396196.834
Cost of Revenue 2,199.6252,142.8262,178.6841,942.3381,936.7312,202.7582,484.2632,844.9342,513.7832,100.3781,990.7931,753.181,691.9271,589.8621,403.9371,270.2231,095.427920.221793.374578.053478.627315.736279.439180.987176.927182.5166.135120.049
Gross Profit 586.113528.142630.071561.395598.19696.321707.548733.719707.593671.565614.921551.755565.096571.278562.769518.659453.542455.514442.426423.7371.089313.824219.979183.963177.209156.545135.26176.785
Gross Profit Ratio 0.210.1980.2240.2240.2360.240.2220.2050.220.2420.2360.2390.250.2640.2860.290.2930.3310.3580.4230.4370.4980.440.5040.50.4620.4490.39
Reseach & Development Expenses 79.14374.1757.01543.70943.91534.12234.80235.97941.04340.13836.41233.8530000000000000000
General & Administrative Expenses 83.17774.2673.28883.44468.12575.02767.83586.86682.52376.15863.6573.89449.31454.377175.698153.727179.51174.578158.066148.362150.589117.98673.54346.12437.27825.62722.47122.362
Selling & Marketing Expenses 86.16685.99999.31663.79676.033164.004166.195131.554131.517140.237129.87127.389109.296135.728127.024117.638104.59496.39772.49669.10668.99937.14346.518.5987.91911.5879.34315.406
SG&A 169.343160.259172.604147.24144.159239.031234.03218.419214.04216.396193.52201.283158.61190.105302.722271.365284.104270.975230.562217.468219.588155.129120.04364.72245.19837.21531.81537.767
Other Expenses 1.423231.233223.795188.853212.883-2.285-4.6030.2749.3971.648-2.558.5950.106-0.3045.9942.294-1.4343.7771.68-1.497-0.1840.123-0.25-2.6413.8042.975.7951.653
Operating Expenses 506.264465.662453.414379.803400.957487.233496.747463.663459.496425.531390.933359.562304.66314.185313.49281.788293.508279.767239.159226.009228.052162.005125.80669.08849.36741.07435.05639.711
Operating Income 116.99894.644197.171180.362340.402363.829222.813283.001322.014305.164245.829218.023261.968274.431300.988108.205425.501279.767213.114152.455181.231177.852155.234146.508132.569120.368102.13834.777
Operating Income Ratio 0.0420.0350.070.0720.1340.1250.070.0790.10.110.0940.0950.1160.1270.1530.060.2750.2030.1720.1520.2130.2830.3110.4010.3740.3550.3390.177
Total Other Income Expenses Net 38.57233.126-2.359-55.235-92.987152.4567.40812.00481.07658.98418.21631.654-0.18215.74656.89-127.484264.03393.1536.184-51.46330.7422.57957.80928.0144.948-0.464-0.336-4.39
Income Before Tax 118.421127.77194.812125.128247.415361.544218.21282.06329.173305.017242.204223.847260.254272.838306.169109.388424.068276.222212.123148.593177.412176.187153.483143.378134.582119.173103.90134.557
Income Before Tax Ratio 0.0430.0480.0690.050.0980.1250.0680.0790.1020.110.0930.0970.1150.1260.1560.0610.2740.2010.1720.1480.2090.280.3070.3930.380.3510.3450.176
Income Tax Expense 11.23413.90441.87731.4763.73972.66645.27959.72567.16959.85552.13944.58849.63440.13642.16215.02266.3964336.87132.76631.17935.67136.67524.13921.62620.03510.783.179
Net Income 99.653105.282120.62693.658145.319241.787137.126180.151208.109197.184155.89143.556165.202192.731220.95882.598307.466201.827157.848112.355132.044128.681108.685118.854112.65298.18992.48831.378
Net Income Ratio 0.0360.0390.0430.0370.0570.0830.0430.050.0650.0710.060.0620.0730.0890.1120.0460.1980.1470.1280.1120.1550.2040.2180.3260.3180.290.3070.159
EPS 0.20.210.240.190.290.480.270.360.410.390.310.280.330.380.440.160.610.420.230.170.190.190.160.160.170.190.180.062
EPS Diluted 0.20.210.240.190.290.480.270.360.410.390.310.280.330.380.440.160.610.420.230.170.190.190.160.160.170.190.180.062
EBITDA 254.209218.984312.633300.241462.838485.25361.367404.647443.927403.962334.686270.425348.067346.7370.313195.743434.633337.291272.029202.222221.201203.345168.928124.814137.965115.471100.20537.074
EBITDA Ratio 0.0910.0820.1110.120.1830.1670.1130.1130.1380.1460.1280.1170.1540.160.1880.1090.2810.2450.220.2020.260.3230.3380.3420.390.3410.3320.188